N/A
Completed N=80
Transversus Abdominis Plane Block Versus Wound Infiltration for Postcesarean Analgesia
Postcesarean Analgesia
Source: ClinicalTrials.gov NCT02691572 ↗
Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Oct 2018
Primary outcomePrimary: Cumulative Fentanyl Dose — 157.4; 153.3 mcg
Summary
The study will compare the analgesic efficacy of transversus abdominis plane block and wound infiltration in parturients undergoing cesarean delivery under spinal anesthesia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cumulative Fentanyl Dose |
— | — |
| SECONDARY Cumulative Fentanyl Dose |
— | — |
| SECONDARY Time to the First Postoperative Fentanyl Administration |
— | — |
| SECONDARY Pain Scores at Rest and Movement |
— | — |
| SECONDARY Number of Patients With Nausea and/or Vomiting |
— | — |
| SECONDARY Level of Sedation |
— | — |
| SECONDARY Number of Patients With Pruritis |
— | — |
| SECONDARY Level of Patient Satisfaction |
— | — |
Eligibility Criteria
Inclusion Criteria
- American Society of Anesthesiologists physical status II
- Full-term singleton pregnancy
Exclusion Criteria
- Age 40 years
- Height <150 cm
- Weight <60 kg
- Body mass index ≥40 kg/m2
- Contraindications to spinal anesthesia (patient refusal, increased intracranial tension, coagulopathy, uncorrected hypovolemia)
- Hypersensitivity to any of the drugs used in the study
- Significant cardiovascular, renal, or hepatic disease
- Known fetal abnormalities
- Emergency situations
Data sourced from ClinicalTrials.gov (NCT02691572). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.